Stocks
Zynerba Pharmaceuticals (ZYNE) P/FCF US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -1.39 | -3.80 | -2.14 | -3.37 | -0.98 | -1.91 | |||
| Changes by years, y/y, % | -78% | +173% | -44% | +58% | -71% | -31.0% | |||
Zynerba Pharmaceuticals. P/FCF
Zynerba Pharmaceuticals. P/FCF, changes, %
Zynerba Pharmaceuticals (ZYNE) P/FCF US GAAP (quarter values) |
||||||||
| 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | LTM ? | |||
| P/FCF | -1.84 | -1.26 | -1.03 | -0.67 | -0.51 | -1.91 | ||
| Changes by years, y/y, % | -69% | -76% | -70% | -80% | -72% | |||
| Changes by quarters, q/q, % | -44% | -31% | -18% | -36% | -23% | |||
